U-Blot® Research Grade LumiliximabCat. No. WA3112$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade LumiliximabCat. No. WA3112
U-Blot® Research Grade LulizumabCat. No. WA3111
U-Blot® Research Grade Lucorafusp AlfaCat. No. WA3110
U-Blot® Research Grade LucatumumabCat. No. WA3109
U-Blot® Research Grade LpathomabCat. No. WA3108
U-Blot® Research Grade lotivibartCat. No. WA3107
U-Blot® Research Grade LosatuxizumabCat. No. WA3106
U-Blot® Research Grade LorvotuzumabCat. No. WA3105
U-Blot® Research Grade Lorukafusp AlfaCat. No. WA3104
U-Blot® Research Grade LorigerlimabCat. No. WA3103
U-Blot® Research Grade LonigutamabCat. No. WA3102
U-Blot® Research Grade loncipoetin alfaCat. No. WA3101